Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A

Anticancer Drugs. 2007 Oct;18(9):1005-14. doi: 10.1097/CAD.0b013e3281e4429d.

Abstract

Trichostatin A and helixor A increased thrombospondin-1 expression by ECV304 cells at both mRNA and protein levels by transcriptional activation through the enhancement of tsp-1 promoter activity. The induction of thrombospondin-1 by these agents potently reduced ECV 304 cell migration and capillary-like tube formation on Matrigel; these findings were confirmed by the neutralization of thrombospondin-1 using a specific antibody. In the presence of exogenous vascular endothelial growth factor, however, these agents had a different effect on the vascular endothelial growth factor-induced tube formation; trichostatin A remarkably inhibited tube formation regardless of the presence of exogenous vascular endothelial growth factor, whereas helixor A reduced it to 70-80% of the control level. Interestingly, when the helixor A-generated conditioned media were concentrated three-fold and the endogenous vascular endothelial growth factor was removed, tube formation was remarkably inhibited compared with the effect of three-fold concentrated conditioned media that had endogenous vascular endothelial growth factor. Additionally, in media with endogenous vascular endothelial growth factor that were concentrated five-fold, tube formation was markedly blocked regardless of the presence of exogenous or endogenous vascular endothelial growth factor. Thus, our results indicate that trichostatin A-induced or helixor A-induced antiangiogenesis is mediated by both agents; increased, absolute and relative levels of thrombospondin-1 to the vascular endothelial growth factor level are critical in angiogenesis.

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Cell Line
  • Cell Movement / drug effects
  • Cell Survival / drug effects
  • Culture Media, Conditioned
  • Dose-Response Relationship, Drug
  • Endothelial Cells / drug effects*
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology
  • Humans
  • Hydroxamic Acids / pharmacology*
  • Neovascularization, Pathologic / metabolism
  • Neovascularization, Pathologic / prevention & control
  • Plant Extracts / pharmacology*
  • Thrombospondin 1 / biosynthesis*
  • Thrombospondin 1 / genetics
  • Up-Regulation
  • Vascular Endothelial Growth Factors / pharmacology

Substances

  • Angiogenesis Inhibitors
  • Culture Media, Conditioned
  • Hydroxamic Acids
  • Plant Extracts
  • Thrombospondin 1
  • Vascular Endothelial Growth Factors
  • trichostatin A
  • Helixor